Please login to the form below

Not currently logged in

Industry leaders calls on EU to combat counterfeits

Pharma industry leaders have called for strong EU measures to combat counterfeit medicines, including a ban on medicine repackaging
Pharma industry leaders have called for strong EU measures to combat counterfeit medicines, including a ban on medicine repackaging.

Speaking at a meeting of the European Federation of Pharmaceutical Industries and Associations (EFPIA), in Paris, chairman of sanofi-aventis and EFPIA's anti-counterfeits champion, Jean-Francois Dehecq said:

"Organised crime gangs operating on an international scale and playing with human lives in the name of profit must be dismantled through determined action, systematic prosecution and appropriate sanctions (civil and penal)."

The EFPIA has made a number of recommendations in a bid to tackle the counterfeiters. These include an EU ban on the repacking of medicine - a practise that is currently legal and undermines efforts to put security features on packaging. A pilot scheme, enabling the pharmacist to verify medicine via a unique bar code system, is to be launched before the end of 2008.

Fake medicines, which can contain incorrect types or volume of active ingredients, are often purchased via the internet. The EFPIA has recognised that better consumer education is needed if people are going to be discouraged from obtaining medicines from illegitimate sources.

Individual companies are also assisting in the crackdown by training their staff to recognise counterfeit drugs.

20th June 2008


Featured jobs

Subscribe to our email news alerts


Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....